Digoxin toxicity and ritonavir: a drug interaction mediated through p-glycoprotein?

被引：10
作者：
Phillips, EJ
Rachlis, AR
Ito, S
机构：
[1] Univ Toronto, Hosp Sick Children, Div Clin Pharmacol, Toronto, ON, Canada
[2] Univ Toronto, Hosp Sick Children, Div Infect Dis, Toronto, ON, Canada
[3] Univ Toronto, Hosp Sick Children, Div Toxicol, Toronto, ON, Canada
[4] Univ Toronto, Hosp Sick Children, Dept Med, Toronto, ON, Canada
[5] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
来源：
AIDS | 2003年 / 17卷 / 10期
关键词：
D O I：
10.1097/00002030-200307040-00026
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1577 / 1578
页数：2
相关论文
共 50 条
  • [41] DRUG-INTERACTION INVOLVING P-GLYCOPROTEIN IN RELATION TO MULTIDRUG RESISTANCE
    ATASSI, G
    TASSIN, JP
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1992, 30 (11) : 526 - 527
  • [42] Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction
    Sun, J
    He, ZG
    Cheng, G
    Wang, SJ
    Hao, XH
    Zou, MJ
    MEDICAL SCIENCE MONITOR, 2004, 10 (01): : RA5 - RA14
  • [43] Drug promiscuity of P-glycoprotein and its mechanism of interaction with paclitaxel and doxorubicin
    Zhang, Junqiao
    Sun, Tianyang
    Liang, Lijun
    Wu, Tao
    Wang, Qi
    SOFT MATTER, 2014, 10 (03) : 438 - 445
  • [44] Evaluation of drug interactions with P-glycoprotein in drug discovery:: In vitro assessment of the potential for drug-drug interactions with P-glycoprotein
    Hochman, JH
    Yamazaki, M
    Ohe, T
    Lin, JH
    CURRENT DRUG METABOLISM, 2002, 3 (03) : 257 - 273
  • [45] Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition
    Verstuyft, C
    Strabach, S
    El Morabet, H
    Kerb, R
    Brinkmann, U
    Dubert, L
    Jaillon, P
    Funck-Brentano, C
    Trugnan, G
    Becquemont, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (01) : 51 - 60
  • [46] Modeling the Kinetics of Digoxin Absorption: Enhancement by P-Glycoprotein Inhibition
    Weiss, Michael
    Sermsappasuk, Pakawadee
    Siegmund, Werner
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (03) : 381 - 387
  • [47] Evidence for Enhanced Intestinal Absorption of Digoxin by P-Glycoprotein Inhibitors
    Valizadeh, Hadi
    Mehtari, Maryam
    Zakeri-Milani, Parvin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2012, 11 (06) : 939 - 945
  • [48] P-GLYCOPROTEIN TRANSPORTER IN DRUG DEVELOPMENT
    Prachayasittikul, Veda
    Prachayasittikul, Virapong
    EXCLI JOURNAL, 2016, 15 : 113 - 118
  • [49] P-GLYCOPROTEIN AND DRUG-RESISTANCE
    CHOU, TH
    CORBETT, TH
    YOST, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 331 - 331
  • [50] Interaction of β-adrenoceptor antagonists with P-glycoprotein
    Bachmakov, I
    Werner, U
    Endress, B
    Auge, D
    Fromm, MF
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 145 - 145
12345